Document Detail


Discontinuation of clonazepam after long-term treatment.
MedLine Citation:
PMID:  2502386     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Frequent unwanted side effects and development of tolerance are the main disadvantages of clonazepam (CZP) in long-term treatment of epileptic patients. A review of the literature shows that CZP tolerance more often appears in severe forms of childhood epilepsy (West and Lennox-Gastaut syndromes) than in other epileptic syndromes. We prospectively studied the consequences of CZP discontinuation in 40 consecutive children with difficult-to-treat epilepsies and multiple-drug therapy. The CZP was reduced stepwise in a variable daily reduction rate (0.003-0.16 mg/kg), while serum levels of the comedication were kept unchanged. In only three children (7.5%), CZP was believed to have had some antiepileptic effect; in 30 (75%) it had been ineffective, whereas in six (15%), a decrease in seizure frequency after CZP discontinuation even suggested a negative therapeutic effect. Discontinuation symptoms, mostly in the form of a transitory exacerbation of seizure frequency, occurred in 19 children (47.5%). These children had a significantly higher CZP dose and longer duration of treatment than did children without discontinuation symptoms, but there was no difference between the two groups related to the rate of CZP discontinuance.
Authors:
U Specht; H E Boenigk; P Wolf
Related Documents :
19263056 - Vagus nerve stimulation in children with intractable epilepsy: indications, complicatio...
16114176 - Nonpharmacological treatment options for epilepsy.
2672786 - Methylphenidate in children with seizures and attention-deficit disorder.
18359276 - Amygdala volume and psychopathology in childhood complex partial seizures.
22685066 - Fatherhood intervention development in collaboration with african american non-resident...
12587856 - Perceptions of stressful life events in northern irish school children: a longitudinal ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Epilepsia     Volume:  30     ISSN:  0013-9580     ISO Abbreviation:  Epilepsia     Publication Date:    1989 Jul-Aug
Date Detail:
Created Date:  1989-09-01     Completed Date:  1989-09-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2983306R     Medline TA:  Epilepsia     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  458-63     Citation Subset:  IM    
Affiliation:
Epilepsie-Zentrum Bethel, Kinderklinik Kidron, Bielefeld, F.R.G.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Child
Child, Preschool
Clonazepam / administration & dosage,  adverse effects*
Drug Tolerance
Epilepsies, Myoclonic / drug therapy
Epilepsies, Partial / drug therapy
Epilepsy / drug therapy
Female
Humans
Male
Prospective Studies
Seizures / chemically induced*
Spasms, Infantile / drug therapy
Substance Withdrawal Syndrome*
Time Factors
Chemical
Reg. No./Substance:
1622-61-3/Clonazepam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical study of oral administration of DN-1417, a TRH analog, in patients with intractable epileps...
Next Document:  Tumor initiation in mouse skin by cutting oils.